These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24716687)
1. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. Doody RS; Farlow M; Aisen PS; N Engl J Med; 2014 Apr; 370(15):1460. PubMed ID: 24716687 [No Abstract] [Full Text] [Related]
2. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. de la Torre JC N Engl J Med; 2014 Apr; 370(15):1459-60. PubMed ID: 24716689 [No Abstract] [Full Text] [Related]
3. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. Laske C N Engl J Med; 2014 Apr; 370(15):1459. PubMed ID: 24716688 [No Abstract] [Full Text] [Related]
4. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. Salloway S; Sperling R; Brashear HR N Engl J Med; 2014 Apr; 370(15):1460. PubMed ID: 24724181 [No Abstract] [Full Text] [Related]
6. Solanezumab for the treatment of mild-to-moderate Alzheimer's disease. Imbimbo BP; Ottonello S; Frisardi V; Solfrizzi V; Greco A; Seripa D; Pilotto A; Panza F Expert Rev Clin Immunol; 2012 Feb; 8(2):135-49. PubMed ID: 22288451 [TBL] [Abstract][Full Text] [Related]
7. [Do antibodies provide advantages for the therapy of Alzheimer's disease? Solanezumab: the jury is still out]. Peters O Dtsch Med Wochenschr; 2014 Mar; 139(10):468. PubMed ID: 24570189 [No Abstract] [Full Text] [Related]
8. Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N‑truncated Abeta in sporadic Alzheimer disease cases and mouse models. Bouter Y; Lopez Noguerola JS; Tucholla P; Crespi GA; Parker MW; Wiltfang J; Miles LA; Bayer TA Acta Neuropathol; 2015 Nov; 130(5):713-29. PubMed ID: 26467270 [TBL] [Abstract][Full Text] [Related]
9. Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return? Panza F; Solfrizzi V; Imbimbo BP; Logroscino G Expert Opin Biol Ther; 2014 Oct; 14(10):1465-76. PubMed ID: 24981190 [TBL] [Abstract][Full Text] [Related]
10. Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis. Arrighi HM; Barakos J; Barkhof F; Tampieri D; Jack C; Melançon D; Morris K; Ketter N; Liu E; Brashear HR J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):106-12. PubMed ID: 25669746 [TBL] [Abstract][Full Text] [Related]
11. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. Doody RS; Thomas RG; Farlow M; Iwatsubo T; Vellas B; Joffe S; Kieburtz K; Raman R; Sun X; Aisen PS; Siemers E; Liu-Seifert H; Mohs R; ; N Engl J Med; 2014 Jan; 370(4):311-21. PubMed ID: 24450890 [TBL] [Abstract][Full Text] [Related]
12. Solanezumab and the amyloid hypothesis for Alzheimer's disease. Le Couteur DG; Hunter S; Brayne C BMJ; 2016 Dec; 355():i6771. PubMed ID: 28034844 [No Abstract] [Full Text] [Related]
17. Antiamyloid therapy for Alzheimer's disease--are we on the right road? Karran E; Hardy J N Engl J Med; 2014 Jan; 370(4):377-8. PubMed ID: 24450897 [No Abstract] [Full Text] [Related]
18. Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive? Tayeb HO; Murray ED; Price BH; Tarazi FI Expert Opin Biol Ther; 2013 Jul; 13(7):1075-84. PubMed ID: 23574434 [TBL] [Abstract][Full Text] [Related]
19. Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. Honig LS; Vellas B; Woodward M; Boada M; Bullock R; Borrie M; Hager K; Andreasen N; Scarpini E; Liu-Seifert H; Case M; Dean RA; Hake A; Sundell K; Poole Hoffmann V; Carlson C; Khanna R; Mintun M; DeMattos R; Selzler KJ; Siemers E N Engl J Med; 2018 Jan; 378(4):321-330. PubMed ID: 29365294 [TBL] [Abstract][Full Text] [Related]
20. Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies. Rygiel K Indian J Pharmacol; 2016; 48(6):629-636. PubMed ID: 28066098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]